RVNC

Revance Therapeutics, Inc. - Common Stock

Investor Moves

Investor	Portfolio Value	Portfolio Change	Position Change	Avg Buy Price	Current Price
Ken GriffinCitadel Advisors $-2.4M ExitQ1 2025 $2.4M -- --
Mario GabelliGAMCO Investors $-177.6K ExitQ1 2025 $178k -- --
Prem WatsaFairfax Financial $-64.1K ExitQ1 2025 $64k -- --
Jim SimonsRenaissance Technologies $-2.4M ExitQ4 2024 $2.4M -- --
Ken GriffinCitadel Advisors $1.8M AddQ4 2024 $1.8M -- --
Paul Tudor Jones IITudor Investment $-376.7K ExitQ4 2024 $377k -- --